| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.92B | +18.1% |
| Cost of Revenue | $1.70B | +13.6% |
| R&D Expense | $1.72B | +14.6% |
| SG&A Expense | $2.02B | +113.2% |
| Operating Income | $1.52B | -15.8% |
| Pre-tax Income | $2.10B | +5.7% |
| Income Tax | -$2.69B | -2902.1% |
| Net Income | $4.79B | +153.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.87B | -6.8% |
| Short-term Investments | $3.20B | +42.5% |
| Current Assets | $16.51B | +11.1% |
| Total Assets | $20.64B | +28.7% |
| Current Liabilities | $9.95B | +24.7% |
| Long-term Debt | $1.99B | +0.2% |
| Total Liabilities | $12.48B | +19.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.88B | +13.2% |
| Investing Cash Flow | -$1.04B | -3621.4% |
| Financing Cash Flow | -$2.43B | -252.7% |
| Stockholders' Equity |
| $8.16B |
| +46.9% |